Susquehanna Fundamental Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$12.1M Buy
94,951
+41,132
+76% +$4.96M 0.24% 96
2021
Q4
$6.64M Buy
53,819
+42,938
+395% +$5.62M 0.17% 143
2021
Q3
$1.55M Sell
10,881
-79,712
-88% -$11.7M 0.03% 692
2021
Q2
$14.1M Sell
90,593
-4,956
-5% -$803K 0.26% 78
2021
Q1
$14.8M Sell
95,549
-18,622
-16% -$2.88M 0.25% 91
2020
Q4
$17.1M Buy
114,171
+39,986
+54% +$5.65M 0.31% 69
2020
Q3
$9.8M Buy
74,185
+18,462
+33% +$2.41M 0.29% 67
2020
Q2
$6.46M Buy
+55,723
New +$6.42M 0.31% 61

Other funds holding ZBH

Susquehanna Fundamental Investments's ZBH Position: Q1 2022 in Review

Susquehanna Fundamental Investments increased its Zimmer Biomet (ZBH) stake by 76% in Q1 2022, buying an estimated $4.96M and bringing the position to 94,951 shares worth $12.1M. The position accounts for 0.24% of the portfolio, ranked #96.

Susquehanna Fundamental Investments first reported a position in ZBH in Q2 2020 and has held it in 8 quarters since. The position peaked at $17.1M in Q4 2020. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

  • Susquehanna Fundamental Investments held 94,951 shares of Zimmer Biomet worth $12.1M as of Q1 2022.
  • Susquehanna Fundamental Investments bought 41,132 Zimmer Biomet shares in Q1 2022, an estimated $4.96M.
  • Zimmer Biomet made up 0.24% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #96 holding.
  • Susquehanna Fundamental Investments first reported a position in Zimmer Biomet in Q2 2020 and has held it in 8 quarters since.
  • Susquehanna Fundamental Investments's Zimmer Biomet position peaked at $17.1M in Q4 2020.
  • 978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.